Healthpeak Properties, Inc. DOC
19.57 USD +0.09 (+0.46%)
At closeNov 3, 2026, 4:00 PM EST
19.56 -0.01 -0.05%
After hours · Nov 3, 4:00 PM ET
19.16 Day range 19.74
15.70 52-week range 22.95
- YTD
- +21.70%
- 1 year
- +10.63%
Analyst view
Consensus: buy
Buy
Price target (mean) 22.39 +14.4% upside
Now 19.57
- Target (low)
- 17.00
- Target (mean)
- 22.39
- Target (high)
- 29.00
Ratings (0m) 22 8 buy · 14 hold · 0 sell
- Strong buy2
- Buy6
- Hold14
- Sell0
- Strong sell0
Recommendation trend
- This month 22
- 1 month ago 22
- 2 months ago 22
- 3 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.025 | 0.02 – 0.04 | 0.0956 | -73.9% | 759.28M | +7.7% | 2 |
| Next quarter | 0.03 | 0.03 – 0.03 | 0.00 | 0.0% | 775.45M | +5.0% | 2 |
| Current year | 0.09 | 0.09 – 0.09 | 0.039 | +130.8% | 2.93B | +6.1% | 1 |
| Next year | 0.14 | 0.12 – 0.16 | 0.09 | +55.6% | 3.17B | +8.2% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 13, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Sep 21, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Aug 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 13, 2026 | Baird | Maintained | Outperform | Outperform |
| Aug 11, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jul 15, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 7, 2026 | Barclays | Initiated | Overweight | Equal-Weight |
| Jul 6, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 24, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jun 15, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jun 11, 2026 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 27, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| May 22, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 14, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 13, 2026 | UBS | Maintained | Neutral | Neutral |
| May 13, 2026 | Baird | Maintained | Outperform | Outperform |
| May 12, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 28, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 20, 2026 | UBS | Initiated | — | Neutral |
| Apr 6, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 1, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Feb 5, 2026 | Argus Research | Downgrade | Buy | Hold |
| Feb 4, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Feb 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
